Related Experiment Video
Updated: Sep 28, 2025

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Case Report of High-Grade Atrioventricular Block and Takotsubo Cardiomyopathy
Rohan Prasad1, Mohammad Fahad Salam1, Shaurya Srivastava1
1Department of Internal Medicine, Michigan State University - Sparrow Hospital, Lansing, MI.
Insights
Takotsubo cardiomyopathy (TTC) complicated by atrioventricular block (AVB) requires prompt treatment. This case highlights successful management with a pacemaker and beta-blockers, improving cardiac function and preventing syncope.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Takotsubo cardiomyopathy (TTC) typically has a good prognosis.
- Atrioventricular block (AVB) is a life-threatening arrhythmia that can complicate TTC.
Observation:
- A 71-year-old woman presented with syncope, hypertension, and bradycardia.
- Electrocardiogram revealed new-onset 2:1 AVB and echocardiogram showed reduced ejection fraction with regional wall motion abnormalities.
- Cardiac catheterization excluded significant coronary artery stenosis, leading to a diagnosis of TTC with AVB.
Findings:
- The patient was treated with lisinopril, metoprolol succinate, and a dual-chamber pacemaker.
- Following treatment, ejection fraction and cardiac function improved.
- The patient experienced no recurrence of syncope, and the pacemaker functioned appropriately.
Implications:
- TTC precipitated by AVB can lead to rapid decompensation and sudden cardiac death.
- Management requires a thorough understanding of this rare complication.
- Pacemakers and beta-blockers are crucial in treating patients with TTC and AVB.
Introduction:
Takotsubo cardiomyopathy (TTC) is a condition with a good long-term prognosis. However, when the TTC is due to a life-threatening arrhythmia, such as atrioventricular block (AVB), several considerations must be made regarding treatment.
Case Presentation:
A 71-year-old woman with a history of ischemic stroke presented after a syncopal episode. Before passing out, the patient was walking, nauseous, lightheaded, dizzy, and short of breath. In the emergency department, the blood pressure was 230/120 mmHg, and the heart rate was 38 beats per minute, but the patient was asymptomatic. An electrocardiogram showed a new-onset 2:1 AVB, bifascicular block, and prolonged PR and corrected QT intervals. An echocardiogram revealed a new-onset ejection fraction of 30% to 35%; hypokinesis of the apex, mid-inferoseptum, mid-anterolateral, apical to mid-inferior, and apical to mid-anterior walls; and hyperkinesis of the basal segments. The cardiac catheterization illustrated normal coronary arteries without significant stenosis. Therefore, the patient was diagnosed with TTC and 2:1 AVB. She was treated with lisinopril and metoprolol succinate and received a dual-chamber pacemaker. At the follow-up visit, the patient's ejection fraction and hypokinetic segments improved. She denied any recurrence of syncope, and her pacemaker was functioning appropriately.
Conclusion:
When AVB or other arrhythmias initiate a TTC, the patient can experience sudden cardiac death and decompensate quickly. Therefore, clinicians should understand this rare but fatal complication because these patients require pacemakers and beta blockers.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis II: Clinical Features and Diagnostic Tests

